Novartis Bioventures Ltd's Net Worth

$156 Million

Estimate Recalculated Jul 8, 2024 05:58PM EST

Who is Novartis Bioventures Ltd?

Novartis Bioventures Ltd has an estimated net worth of $156 Million. This is based on reported shares across multiple companies, which include Akouos, Inc., Forma Therapeutics Holdings, Inc.,, Galera Therapeutics, Inc., BICYCLE THERAPEUTICS plc, AILERON THERAPEUTICS INC, Altimmune, Inc., Aerpio Pharmaceuticals, Inc., Ra Pharmaceuticals, Inc., Aeglea BioTherapeutics, Inc., PROTEOSTASIS THERAPEUTICS, INC., Tokai Pharmaceuticals Inc, Marina Biotech, Inc., Celladon Corp, and Akebia Therapeutics, Inc..

SEC CIK

Novartis Bioventures Ltd's CIK is 0001297709

Past Insider Trading and Trends

2018 was Novartis Bioventures Ltd's most active year for acquiring shares with 12 total transactions. Novartis Bioventures Ltd's most active month to acquire stocks was the month of January. 2011 was Novartis Bioventures Ltd's most active year for disposing of shares, totalling 79 transactions. Novartis Bioventures Ltd's most active month to dispose stocks was the month of December. 2014 saw Novartis Bioventures Ltd paying a total of $9,410,414.00 for 9,627,294 shares, this is the most they've acquired in one year. In 2020 Novartis Bioventures Ltd cashed out on 2,131,364 shares for a total of $8,957,134.68, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Akouos, Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
1.18M
$17.00
—
1.18M
Jun 30
Form 3
—
0
—
—
0
No matching records found

Forma Therapeutics Holdings, Inc., No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 3
—
0
—
—
0
No matching records found

Galera Therapeutics, Inc. (GRTX) Snapshot price: $0.1709

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-28.88%
-1.00M
$8.25
-$8,268,960.00
2.47M
Jun 18 - Jun 19
Form 4
-0.56%
-19.39K
$9.21
-$178,610.14
3.47M
Jun 15 - Jun 17
Form 4
-0.49%
-17.23K
$9.33
-$160,809.72
3.49M
Jun 10 - Jun 12
Form 4
-0.60%
-21.31K
$9.57
-$203,904.26
3.51M
Jun 5 - Jun 9
Form 4
-0.42%
-14.96K
$9.68
-$144,850.56
3.53M
Jun 2 - Jun 4
Form 4
∞
3.54M
$12.00
—
3.54M
Nov 12
Form 3
—
0
—
—
0
No matching records found

BICYCLE THERAPEUTICS plc (BCYC) Snapshot price: $17.13

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
1.77M
$14.00
—
1.77M
May 28
Form 3
—
0
—
—
0
No matching records found

AILERON THERAPEUTICS INC (ALRN) Snapshot price: $4.95

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-5.76%
-127.15K
$1.86
-$236,258.00
2.08M
Mar 29 - Apr 1
Form 4
-7.94%
-190.34K
$2.06
-$391,444.56
2.21M
Mar 13 - Mar 15
Form 4
-0.84%
-20.39K
$2.30
-$46,892.40
2.4M
Aug 20
Form 4
-0.72%
-17.51K
$2.10
-$36,766.80
2.42M
Aug 16 - Aug 17
Form 4
-0.24%
-5.93K
$2.21
-$13,123.25
2.43M
Aug 14 - Aug 15
Form 4
-0.29%
-7.21K
$2.42
-$17,476.60
2.44M
Aug 10 - Aug 13
Form 4
-0.05%
-1.24K
$2.72
-$3,362.80
2.45M
Aug 8 - Aug 9
Form 4
-0.19%
-4.68K
$3.00
-$14,049.67
2.45M
Aug 6 - Aug 7
Form 4
-0.19%
-4.70K
$3.33
-$15,657.66
2.45M
Aug 2
Form 4
-0.51%
-12.68K
$3.17
-$40,157.82
2.46M
Jul 31 - Aug 1
Form 4
-0.34%
-8.46K
$3.35
-$28,368.04
2.47M
Jul 27 - Jul 30
Form 4
-0.82%
-20.40K
$3.76
-$76,657.71
2.48M
Jul 25 - Jul 26
Form 4
-1.24%
-31.30K
$4.25
-$132,927.00
2.5M
Jul 23 - Jul 24
Form 4
-0.50%
-12.80K
$4.72
-$60,420.00
2.53M
Jul 16 - Jul 17
Form 4
∞
2.54M
$15.00
—
2.54M
Jul 5
Form 3
—
0
—
—
0
No matching records found